We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Gear Up for Bruker (BRKR) Q2 Earnings: Wall Street Estimates for Key Metrics
Read MoreHide Full Article
In its upcoming report, Bruker (BRKR - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.52 per share, reflecting an increase of 4% compared to the same period last year. Revenues are forecasted to be $796.23 million, representing a year-over-year increase of 16.8%.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
With that in mind, let's delve into the average projections of some Bruker metrics that are commonly tracked and projected by analysts on Wall Street.
The consensus among analysts is that 'Revenue- Bruker Energy & Supercon Technologies (BEST)' will reach $78.32 million. The estimate points to a change of +7.7% from the year-ago quarter.
It is projected by analysts that the 'Organic revenue growth - Total' will reach 6.9%. Compared to the current estimate, the company reported 13.5% in the same quarter of the previous year.
Analysts forecast 'Organic revenue growth - Bruker Scientific Instruments (BSI)' to reach 7.7%. The estimate compares to the year-ago value of 13%.
Based on the collective assessment of analysts, 'Organic revenue growth - Bruker Energy & Supercon Tech (BEST)' should arrive at 4.4%. The estimate compares to the year-ago value of 18.4%.
Shares of Bruker have demonstrated returns of +6.9% over the past month compared to the Zacks S&P 500 composite's -2.9% change. With a Zacks Rank #3 (Hold), BRKR is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Gear Up for Bruker (BRKR) Q2 Earnings: Wall Street Estimates for Key Metrics
In its upcoming report, Bruker (BRKR - Free Report) is predicted by Wall Street analysts to post quarterly earnings of $0.52 per share, reflecting an increase of 4% compared to the same period last year. Revenues are forecasted to be $796.23 million, representing a year-over-year increase of 16.8%.
The consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This represents how the covering analysts, as a whole, have reassessed their initial estimates during this timeframe.
Prior to a company's earnings release, it is of utmost importance to factor in any revisions made to the earnings projections. These revisions serve as a critical gauge for predicting potential investor behaviors with respect to the stock. Empirical studies consistently reveal a strong link between trends in earnings estimate revisions and the short-term price performance of a stock.
While investors typically use consensus earnings and revenue estimates as a yardstick to evaluate the company's quarterly performance, scrutinizing analysts' projections for some of the company's key metrics can offer a more comprehensive perspective.
With that in mind, let's delve into the average projections of some Bruker metrics that are commonly tracked and projected by analysts on Wall Street.
The consensus among analysts is that 'Revenue- Bruker Energy & Supercon Technologies (BEST)' will reach $78.32 million. The estimate points to a change of +7.7% from the year-ago quarter.
It is projected by analysts that the 'Organic revenue growth - Total' will reach 6.9%. Compared to the current estimate, the company reported 13.5% in the same quarter of the previous year.
Analysts forecast 'Organic revenue growth - Bruker Scientific Instruments (BSI)' to reach 7.7%. The estimate compares to the year-ago value of 13%.
Based on the collective assessment of analysts, 'Organic revenue growth - Bruker Energy & Supercon Tech (BEST)' should arrive at 4.4%. The estimate compares to the year-ago value of 18.4%.
View all Key Company Metrics for Bruker here>>>
Shares of Bruker have demonstrated returns of +6.9% over the past month compared to the Zacks S&P 500 composite's -2.9% change. With a Zacks Rank #3 (Hold), BRKR is expected to mirror the overall market performance in the near future. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>